Altimmune, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2023 Annual Meeting of Stockholders held by Altimmune, Inc. on September 28, 2023. The record date for the meeting was August 11, 2023, with 52,686,426 shares of common stock outstanding and entitled to vote.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 34,561,978 shares were present or represented by proxy, representing 65.6% of issued and outstanding shares, establishing a quorum. The following proposals were voted upon:
- Proposal 1 (Election of Directors): All nine nominees were elected. Notable withhold votes included Wayne Pisano (2,775,585) and David J. Drutz (2,281,084). Broker non-votes totaled 12,400,518 for all director nominees.
- Proposal 2 (Ratification of Auditors): Stockholders approved the appointment of Ernst & Young LLP with 34,318,768 votes For, 153,149 Against, and 90,061 Abstain.
- Proposal 3 (Say-on-Pay): The advisory vote on executive compensation passed with 16,834,432 votes For, 5,221,648 Against, and 105,380 Abstain. Broker non-votes totaled 12,400,518.
- Proposal 4 (Frequency of Say-on-Pay): Stockholders approved an annual frequency for future say-on-pay votes. Results: 21,595,590 for 1 Year, 80,595 for 2 Years, 352,096 for 3 Years, and 133,179 Abstain.
- Proposal 5 (Adjournment Authorization): Stockholders approved the authorization to adjourn the meeting to solicit additional proxies with 27,712,554 votes For, 6,744,992 Against, and 104,432 Abstain.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The Board of Directors determined that future advisory votes on executive compensation will be held on an annual basis based on the voting results.
Key Facts for Investor Verification
- Verify the specific reasons for the significant number of "Withhold" votes for directors Wayne Pisano and David J. Drutz.
- Confirm the Board's rationale for holding future say-on-pay votes annually despite the advisory nature of the vote.
- Review the full Proxy Statement for detailed executive compensation data referenced in Proposal 3.
- Check subsequent filings for any operational updates or financial results not included in this governance-focused 8-K.